Triferic AVNU Infusion Via Freedom Pump During Hemodialysis

Completed · Phase 4

Conditions studied: End Stage Renal Disease

In brief

The main purpose of this study is to evaluate the delivery of Triferic AVNU intravenously using the Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.

Key facts

Study ID

NCT04689932

Run by

Rockwell Medical Technologies, Inc.

People needed

12

Starts

2021-04-19

Expected to finish

2021-06-19

Last updated by the study team

2022-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant must be 18 years of age inclusive, at the time of signing the informed consent.
• Receiving chronic hemodialysis for 3-4 hours each session 3x/week.
• Medically stable according to the investigator opinion
• Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.

You may not qualify if…

• Hemodynamically unstable during hemodialysis
• Evidence of active bleeding from the GI tract.

Where it is running

• Luxury Dialysis — Webster, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.